About Us
|
Market
|
Technology
|
Investors
News
|
Contact
Home
|
Site Map
|
RSS Feeds
OTCBB:
ORGS
0.90
0.00 (0.00%) | May 18, 2013
About Us
Profile
Corporate
Officers
Directors
Advisory Board
Committees
Market
Overview
Diabetes
Existing Treatments
Our Opportunity
Technology
Concept
Product
Treatment
Development
Clinical Trials
Articles
Risk Factors
Investors
Share Price
SEC Filings
Presentations
News Releases
News
News Releases
Events
Media
RSS Feeds
Contact
Company
News Alert
Trials
Careers
Orgenesis.com
Site Map
Terms and Conditions
Privacy Policy
Glossary
Site Map
About Us
Profile
Corporate
Officers
Directors
Advisory Board
Committees
Market
Overview
Diabetes
Existing Treatments
Our Opportunity
Technology
Concept
Product
Treatment
Development
Clinical Trials
Articles
Risk Factors
Investors
Share Price
SEC Filings
XBRL Filings
Presentations
News Releases
News
News Releases
Events
Media
RSS Feeds
Site
Site Map
Terms and Conditions
Privacy Policy
Glossary
DIABETES -
A MODERN EPIDEMIC
The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030
...read more
OUR TECHNOLOGY
An innovative treatment with wide implications using a patient’s own tissue to restore damaged organs
...read more
CLINICAL TRIALS
The initial product is an overall clinical treatment for the diabetic patient...
...read more